Today, the U.S. Food and Drug Administration’s Center for Veterinary Medicine published the 2022 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.
Read the report at 2022 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.
This year’s data show that domestic sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals increased by four percent between 2021 and 2022; compared to 2015 (peak year of sales), 2022 sales were down 36 percent. Sales volume may fluctuate over time in response to various factors, including changing animal health needs or changes in animal populations.
The 2022 data are published in a new dashboard reporting format that allows users to interact with the data and create data visualizations using criteria such as antimicrobial drug class, species, and year. The annual sales data are also available in an Excel spreadsheet. The FDA intends to continue this approach for annual sales and distribution summary reports in the future.
While sales data on antimicrobial drug products intended for food-producing animals do not necessarily reflect the actual use of antimicrobial drugs, sales volume observed over time can be a valuable indicator of market trends related to these products. However, when evaluating the progress of ongoing antimicrobial stewardship in veterinary settings, it is important consider additional information sources including actual use data, animal demographics, animal health data, and data on antimicrobial resistance.
Read more at FDA
[Source: FDA 7 December 2023]